This activator contains lots of substances activating cells including various kinds of growth factors which help activate the stem cell in human body.

Scientists of the Branch also established a method of manufacturing new stem cell activator efficacious for ischemia and settled various sci-tech problems arising in manufacturing stem cell activator injection, a biomedicine of new generation.

According to clinical examination at the Kim Man Yu Hospital, the Institute of Koryo Medicine and other health service units, the new biomedicine has been proved to be very efficacious for spontaneous gangrene and ischemic encephalopathy.

Now the Branch is stepping up the work to build the processes for producing the stem cell activator and injection.